Terms: = Uterine cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
119 results:
1. HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1α/VEGF signaling pathway.
Liu L; Gu K; Hua D
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):132-140. PubMed ID: 38015530
[TBL] [Abstract] [Full Text] [Related]
2. Gestational choriocarcinoma.
Bogani G; Ray-Coquard I; Mutch D; Vergote I; Ramirez PT; Prat J; Concin N; Ngoi NYL; Coleman RL; Enomoto T; Takehara K; Denys H; Lorusso D; Takano M; Sagae S; Wimberger P; Segev Y; Kim SI; Kim JW; Herrera F; Mariani A; Brooks RA; Tan D; Paolini B; Chiappa V; Longo M; Raspagliesi F; Benedetti Panici P; Di Donato V; Caruso G; Colombo N; Pignata S; Zannoni G; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Oct; 33(10):1504-1514. PubMed ID: 37758451
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasound Microvessel Visualization in Cervical cancer: Association Between Novel Ultrasound Techniques and Histologic Microvessel Densities.
Zhong J; Huang L; Su M; Wu M; Lin X; Shui X; Jiang Y; Zhang X
Ultrasound Med Biol; 2023 Dec; 49(12):2537-2547. PubMed ID: 37730477
[TBL] [Abstract] [Full Text] [Related]
4. vegfr2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
Zhong J; Su M; Jiang Y; Huang L; Chen Y; Huang Z; Zhang X
J Nanobiotechnology; 2023 Jul; 21(1):220. PubMed ID: 37438780
[TBL] [Abstract] [Full Text] [Related]
5. Design, Synthesis, and Anti-Cervical cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives.
Yang Z; Liu ZY; Ablise M; Maimaiti A; Mutalipu Z; Alimujiang Y; Aihaiti A
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299013
[TBL] [Abstract] [Full Text] [Related]
6. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of vegfr2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
8. Resveratrol against Cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/vegfr2 inhibitors targeting cancer.
El-Khouly OA; Henen MA; El-Sayed MA; El-Messery SM
Sci Rep; 2022 Oct; 12(1):17104. PubMed ID: 36224254
[TBL] [Abstract] [Full Text] [Related]
10. The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.
Berger AA; Kawaler EA; Dao F; Misirlioglu S; Fernandez EA; Olvera N; Van Oudenhove E; DeLair D; Levine DA
Gynecol Oncol; 2022 Nov; 167(2):323-333. PubMed ID: 36150916
[TBL] [Abstract] [Full Text] [Related]
11. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical cancer in a Subcutaneous Xenograft Mouse Model.
Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
[TBL] [Abstract] [Full Text] [Related]
12. Significance of HER2 and vegfr2 in Early-stage Endometrial cancer.
An HJ; Song DH; Kim YM; Jo HC; Baek JC; Park JE
In Vivo; 2022; 36(2):723-730. PubMed ID: 35241527
[TBL] [Abstract] [Full Text] [Related]
13. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer.
Baeten IGT; Hoogendam JP; Jonges GN; Jürgenliemk-Schulz IM; Braat AJAT; van Diest PJ; Gerestein CG; Zweemer RP
Gynecol Oncol; 2022 May; 165(2):257-263. PubMed ID: 35219527
[TBL] [Abstract] [Full Text] [Related]
14. Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3.
Zhong L; Tang L; He X
Bioengineered; 2022 Feb; 13(2):2971-2980. PubMed ID: 35038961
[TBL] [Abstract] [Full Text] [Related]
15. A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical cancer After Failure of First-Line Therapy.
Yang H; Sun S; Mei Z; Xiang Q; Yang C; Chen M; Xie C; Zhou Y; Qiu H
Drug Des Devel Ther; 2021; 15():4665-4674. PubMed ID: 34815663
[TBL] [Abstract] [Full Text] [Related]
16. Anti-tumour effect of in situ vaccines combined with vegfr inhibitors in the treatment of metastatic cervical cancer.
Liu L; Cai L; Du X; Zhao J; Zhao Y; Zou C; Yu S; Zhang C; Ye P; Su X; Yan X; Li W
Int Immunopharmacol; 2021 Dec; 101(Pt B):108302. PubMed ID: 34717193
[TBL] [Abstract] [Full Text] [Related]
17. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
18. Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical cancer.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Chen Z; Long X; Pang Q; Peng L; Li X; Gu J; Deng S; Xing L
Oncol Res; 2022 Jan; 28(9):929-944. PubMed ID: 34544526
[TBL] [Abstract] [Full Text] [Related]
19. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/vegfr2 and ERK1/2 signaling in endometrial cancer.
Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
[TBL] [Abstract] [Full Text] [Related]
20. Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.
Li Z; Chen C; Liu P; Lu A; Zhao H; Zhan X; Duan H; Li P; Zhao W; Yao J; Li D; Jiang H; Liu M; Bin X; Lang J
Arch Gynecol Obstet; 2022 Feb; 305(2):449-458. PubMed ID: 34406459
[TBL] [Abstract] [Full Text] [Related]
[Next]
